DIA Medical Affairs forum 2021 in Japan
Sonoko Misawa, MD, PhD
- Associate Professor
- Chiba University, Japan
Tadashi Urashima, PhD
- Performance and Digital Analytics Lead, Medical & Development Excellence Japan
- GlaxoSmithKline K.K., Japan
Dr. Tadashi Urashima is MSL manager at GlaxoSmithKline K.K. Dr. Urashima is leading MSL activity in Specialty area as a MSL manager. In addition to the position, Dr. Urashima is leading digital engagement for medical activities. Dr. Urashima has extensive experiences such as clinical development, medical excellence, change management etc 20 years at GSK. Dr. Urashima has a certification of LSS MBB and contributed to various business improvement. Dr. Urashima holds a PhD for regenerative medicine in Tottori University. Dr. Urashima has been certified as Professional Coach in Foundation of Global Life Learning Center. Also. Dr. Urashima is DIA MA community member and played sub chair at 1st DIA MA Forum which took place this September.
Shinichi Nishiuma, MD
- Head of Oncology Medical Science, Japan medical
- BMS, Japan
Dr. Shinichi Nishiuma is Head of Oncology Medical Science, Japan medical at Bristol Myers Squibb In this position, Dr. Nishiuma is responsible for leading and overseeing all medical activities across Celgene Japan. Dr. Nishiuma has over 15 years' experience in pharmaceutical industries, including clinical development, drug safety, RWE/epidemiology and medical affairs. Dr. Nishiuma holds M.D. from Kobe University and worked at Kobe city general hospital as a gastroenterologist prior to joining the industry. Dr. Nishiuma also serves as a board member and vice-president at Japanese association of pharmaceutical medicine.
Mitsutoshi Toda, MBA
- Group Manager, CRM Medical Franchise Dept. Japan Medical Division
- Novartis Pharma K.K., Japan
Shuji Uno, PhD
- Medical Lead, Hematology, Japan Medical
- Bristol-Myers Squibb K.K., Japan
Shuji Uno has served as Medical Lead at Medical Affairs department in BMS K.K. since July 2020. Shuji is responsible for Medical Plan development via UMNs identification and any activities of Evidence Generation in hematology area, such as company-sponsored studies, investigator-sponsored studies, and publication. He has over 8 years of experineces in Medical Affairs department including field work experiences as MSL in pharmaceutical industry. He holds a Ph.D. in life science from University of Tokyo.
- Sr. Vice President, Managing Director
- SH DIA Japan, Japan
Hajime “Jim” Saijo, PhD, MBA, is the Sr. VP, managing director of DIA Japan. He previously established and lead the Academia Clinical Research Division, CMIC K.K., as Corporate Officer managing clinical research and investigator sponsored clinical trials. Dr. Saijo’s experience also includes serving as Director of R&D for Alcon Japan; Director of R&D and Representative Director for start-up operations of Ferring Pharmaceuticals Co. Ltd.; and as VP of Medical, Clinical and Regulatory Affairs for Japan & APEC for OvaScience. Dr. Saijo earned his PhD in Medical Science from Tokyo Medical and Dental University Graduate School of Medicine and Dentistry, and his MBA in Business Administration from Temple University Business School, Japan Campus.
Jun Fukuyoshi, MBA
- CEO & Founder
- Cancerscan Inc., Japan
- PwC Consulting LLC, Japan
Hideki Ninomiya, MD
- Datack Inc, Japan
Hideki Ninomiya graduated from the University of Tokyo's School of Medicine. After working as a neurosurgeon, he entered the world of data science. He engaged in medical information and telemedicine at Medley Inc. Afterwards, he started his own company, Datack Inc.
- Associate Manager, Digital Compliance Group, Business Strategy & Compliance Dept
- Chugai Pharmaceutical Co., Ltd., Japan
Koji Kawakami, MD, PhD
- Professor and Chair, Department of Pharmacoepidemiology
- Graduate School of Medicine and Public Health, Kyoto University, Japan
Koji Kawakami, MD, PhD is Professor and Chair, Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University. After the residency training in head and neck surgery and otorhinolaryngology, Dr. Kawakami served as postdoc and later promoted to clinical trial (IND) reviewer at CBER of U.S. FDA from 1999-2004. In 2006, Dr. Kawakami moved to Kyoto University to serve his current position, where he conducts various research programs focusing on clinical epidemiology and pharmaco epidemiology, and cost effectiveness researches utilizing various medical and healthcare databases. He has published more than 140 original articles in peer-reviewed global scientific journals as of August 2016.
Atsushi Mizuno, MD, PhD, MBA
- Department of Cardiology, QI center
- St. Luke's International Hospital, Japan
- Sr Manager, Medical Contetn, Medical Excellence
- Bristol-Myers Squibb.K.K. , Japan
Takashi Moriya, PhD, MBA
- Product Owner (Senior Manager) - Healthcare
- Woven Alpha, Inc. (Woven Planet Holdings, Inc. group company), Japan
Takashi is a director of Data Sciences, newly established department, in Janssen Japan R&D Division since June, 2019. His professional experiences range from Discovery Research, Clinical Development to Medical Affairs in Liver, Diabetes, Cardiovascular/Metabolic, Infection, Hematology and others. He also has extensive experiences in Clinical Statistics and IT system/database/sofware development during his 19-years of pharma industry career (Pfizer, RaQualia, Eli Lilly, Gilead and Chugai/Roche) after graduating from Duke University in Chemistry and Toxicology (2000). He holds a Ph.D. degree (2012) in NASH research from Nagoya University's Medical School and an Executive MBA degree (2018) from Keio Business School while he worked full-time.
- Medical Manager
- Sanofi K.K., Japan
Dr. Yoshiyuki Sugimoto is the Scientifica Advisor in Medical Affairs at AbbVie Japan. Dr. Sugimoto graduated from Faculty of Pharmaceutical Sciences, the University of Tokyo in 1998 and completed Master's course at Graduate School of Pharmaceutical Science, the University of Tokyo in 2000. Dr. Sugimoto Joined Kyowa Hakko Kogyo Co., Ltd. (current Kyowa Kirin Co., Ltd.) in 2000, and moved to AbbVie Japan in 2016. Dr. Sugimoto has over 20 years’ experience in Pharmaceutical industry including Research, Development and Medical Affairs. Currently Dr. Sugimoto works for Rheumatology Medical Affairs Team and plays a leading role in the strategy of rheumatology field. Dr. Sugimoto obtained PhD degree from Waseda University in 2014.
Tetsuya Watanabe, RPh
- Senior Medical Director, Medical Affairs
- Astellas Pharma Inc., Japan